Oncotarget

Vol 10, No 32

April 30, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 32 of Oncotarget features Figure 5, "Model of potential mechanisms by which soluble factors from the primary breast tumors may induce an anti-inflammatory state within premetastatic tissues," by Meade, et al.

Table of Contents

Research Papers

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers

https://doi.org/10.18632/oncotarget.26892

Yosuke Osawa, Ekumi Kojika, Koji Nishikawa, Masamichi Kimura, Shigenori Osakaya, Hiromi Miyauchi, Tatsuya Kanto, Yutaka Kawakami,  and Kiminori Kimura
3013-3026
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung

Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung

https://doi.org/10.18632/oncotarget.26903

Kayla J. Meade, Francesca Sanchez, Analine Aguayo, Nathalie Nadales, Sarkis G. Hamalian, Toni L. Uhlendorf, Lisa R. Banner,  and Jonathan A. Kelber
3027-3039
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs

A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs

https://doi.org/10.18632/oncotarget.26889

Hugh Giovinazzo, David Walker, Nicolas Wyhs, Jianyong Liu, David M. Esopi, Ajay M. Vaghasia, Yash Jain, Akshay Bhamidipati, Jianya Zhou, William G. Nelson,  and Srinivasan Yegnasubramanian
3040-3050
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells

Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells

https://doi.org/10.18632/oncotarget.26890

María Celeste Díaz Flaqué, Maria Florencia Cayrol, Helena Andrea Sterle, María del Rosario Aschero, Johanna Abigail Díaz Albuja, Blanca Isse, Ricardo Norberto Farías, Leandro Cerchietti, Cinthia Rosemblit,  and Graciela Alicia Cremaschi
3051-3065
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Reviews

Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer

Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer

https://doi.org/10.18632/oncotarget.24684

Hang Yang, Jiang-Tao Zhong, Shui-Hong Zhou,  and He-Ming Han
3066-3083
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC